358 related articles for article (PubMed ID: 15351403)
1. Peptidyl allyl sulfones: a new class of inhibitors for clan CA cysteine proteases.
Götz MG; Caffrey CR; Hansell E; McKerrow JH; Powers JC
Bioorg Med Chem; 2004 Oct; 12(19):5203-11. PubMed ID: 15351403
[TBL] [Abstract][Full Text] [Related]
2. Optimization of peptidyl allyl sulfones as clan CA cysteine protease inhibitors.
Fennell BD; Warren JM; Chung KK; Main HL; Arend AB; Tochowicz A; Götz MG
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):468-78. PubMed ID: 22380780
[TBL] [Abstract][Full Text] [Related]
3. Nonpeptidic vinyl and allyl phosphonates as falcipain-2 inhibitors.
Ettari R; Nizi E; Di Francesco ME; Micale N; Grasso S; Zappalà M; Vicík R; Schirmeister T
ChemMedChem; 2008 Jul; 3(7):1030-3. PubMed ID: 18428116
[No Abstract] [Full Text] [Related]
4. Dipeptidyl-alpha,beta-epoxyesters as potent irreversible inhibitors of the cysteine proteases cruzain and rhodesain.
González FV; Izquierdo J; Rodríguez S; McKerrow JH; Hansell E
Bioorg Med Chem Lett; 2007 Dec; 17(24):6697-700. PubMed ID: 17977725
[TBL] [Abstract][Full Text] [Related]
5. Solid-phase synthesis of peptide vinyl sulfones as potential inhibitors and activity-based probes of cysteine proteases.
Wang G; Mahesh U; Chen GY; Yao SQ
Org Lett; 2003 Mar; 5(5):737-40. PubMed ID: 12605503
[TBL] [Abstract][Full Text] [Related]
6. Aspartic vinyl sulfones: inhibitors of a caspase-3-dependent pathway.
Glória PM; Coutinho I; Gonçalves LM; Baptista C; Soares J; Newton AS; Moreira R; Saraiva L; Santos MM
Eur J Med Chem; 2011 Jun; 46(6):2141-6. PubMed ID: 21439692
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of macrocyclic trypanosomal cysteine protease inhibitors.
Chen YT; Lira R; Hansell E; McKerrow JH; Roush WR
Bioorg Med Chem Lett; 2008 Nov; 18(22):5860-3. PubMed ID: 18585034
[TBL] [Abstract][Full Text] [Related]
8. Fasciola gigantica: evaluation of the effect of phenyl vinyl sulfone in vitro.
Helmy MM; Fahmy ZH; Sabry HY
Exp Parasitol; 2008 May; 119(1):125-34. PubMed ID: 18291373
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors.
Rocha DA; Silva EB; Fortes IS; Lopes MS; Ferreira RS; Andrade SF
Eur J Med Chem; 2018 Sep; 157():1426-1459. PubMed ID: 30282318
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones.
Shenai BR; Lee BJ; Alvarez-Hernandez A; Chong PY; Emal CD; Neitz RJ; Roush WR; Rosenthal PJ
Antimicrob Agents Chemother; 2003 Jan; 47(1):154-60. PubMed ID: 12499184
[TBL] [Abstract][Full Text] [Related]
11. Novel peptidyl aryl vinyl sulfones as highly potent and selective inhibitors of cathepsins L and B.
Mendieta L; Picó A; Tarragó T; Teixidó M; Castillo M; Rafecas L; Moyano A; Giralt E
ChemMedChem; 2010 Sep; 5(9):1556-67. PubMed ID: 20652927
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of dipeptidyl alpha',beta'-epoxy ketones, potent irreversible inhibitors of the cysteine protease cruzain.
Roush WR; González FV; McKerrow JH; Hansell E
Bioorg Med Chem Lett; 1998 Oct; 8(19):2809-12. PubMed ID: 9873627
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
[TBL] [Abstract][Full Text] [Related]
14. Activity-based fingerprinting and inhibitor discovery of cysteine proteases in a microarray.
Uttamchandani M; Liu K; Panicker RC; Yao SQ
Chem Commun (Camb); 2007 Apr; (15):1518-20. PubMed ID: 17406693
[TBL] [Abstract][Full Text] [Related]
15. Development of peptidomimetics with a vinyl sulfone warhead as irreversible falcipain-2 inhibitors.
Ettari R; Nizi E; Di Francesco ME; Dude MA; Pradel G; Vicík R; Schirmeister T; Micale N; Grasso S; Zappalà M
J Med Chem; 2008 Feb; 51(4):988-96. PubMed ID: 18232656
[TBL] [Abstract][Full Text] [Related]
16. Development of cell-active non-peptidyl inhibitors of cysteine cathepsins.
Dana D; Davalos AR; De S; Rathod P; Gamage RK; Huestis J; Afzal N; Zavlanov Y; Paroly SS; Rotenberg SA; Subramaniam G; Mark KJ; Chang EJ; Kumar S
Bioorg Med Chem; 2013 Jun; 21(11):2975-87. PubMed ID: 23623677
[TBL] [Abstract][Full Text] [Related]
17. Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C).
Kam CM; Götz MG; Koot G; McGuire M; Thiele D; Hudig D; Powers JC
Arch Biochem Biophys; 2004 Jul; 427(2):123-34. PubMed ID: 15196986
[TBL] [Abstract][Full Text] [Related]
18. Antiprotozoal and cysteine proteases inhibitory activity of dipeptidyl enoates.
Royo S; Schirmeister T; Kaiser M; Jung S; Rodríguez S; Bautista JM; González FV
Bioorg Med Chem; 2018 Sep; 26(16):4624-4634. PubMed ID: 30037754
[TBL] [Abstract][Full Text] [Related]
19. Vinyl sulfone-based inhibitors of trypanosomal cysteine protease rhodesain with improved antitrypanosomal activities.
Zhang H; Collins J; Nyamwihura R; Crown O; Ajayi O; Ogungbe IV
Bioorg Med Chem Lett; 2020 Jul; 30(14):127217. PubMed ID: 32527539
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl alpha-fluorovinyl Michael acceptors: synthesis and activity against cysteine proteases.
Steert K; El-Sayed I; Van der Veken P; Krishtal A; Van Alsenoy C; Westrop GD; Mottram JC; Coombs GH; Augustyns K; Haemers A
Bioorg Med Chem Lett; 2007 Dec; 17(23):6563-6. PubMed ID: 17936625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
